BIOGEN INC. 8-K

What Happened

• Biogen Inc. announced its results of operations and financial condition for the quarter ended March 31, 2026. The company issued a press release dated April 29, 2026 and furnished that release as Exhibit 99.1 to a Form 8-K filed on April 29, 2026. The Form 8-K reports this information under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Filing date: April 29, 2026 (Form 8-K).
• Quarter covered: Quarter ended March 31, 2026 (Q1 2026).
• Press release: Furnished as Exhibit 99.1 to the Form 8-K.
• Form signed by Wendell Taylor, Secretary, on April 29, 2026.

Why It Matters

• This 8-K notifies investors that Biogen has released its quarterly earnings and related financial information; investors should review the furnished press release (Exhibit 99.1) for specifics on revenue, earnings per share, operating results and any commentary on guidance or business drivers.
• Because the filing is an Item 2.02 disclosure, it signals the company has publicly disclosed its quarterly performance; that information can affect stock valuation, analyst estimates, and short-term trading around earnings news.